跳至主要内容
临床试验/JPRN-UMIN000021320
JPRN-UMIN000021320已完成未知

Efficacy and Safety of Eyebon Eye Wash Solution in Allergic Conjunctivitis after Conjunctival Cedar Pollen Allergen Challenge - Efficacy and Safety of Eyebon Eye Wash Solution in Allergic Conjunctivitis

Tsurumi University0 个研究点目标入组 15 人开始时间: 2016年3月11日最近更新:

试验速览

阶段
未知
状态
已完成
入组人数
15

研究概览

简要总结

The 199th Annual Meeting of the Japanese Ophthalmological Society (2015)

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. have had a history of allergic hypersensitivity or known hypersensitivity to any compound or excipient of the Eyebon Eye Wash 2. have had the presence of any ocular condition that could affect the patient's safety or study parameters (narrow angle glaucoma requiring medication or laser treatment, clinically significant blepharitis, follicular conjunctivitis, iritis, pterygium, or a diagnosis of dry eye). 3. have had a known history of vernal keratoconjunctivitis and/or atopic eratoconjunctivitis; 4. have had an ocular surgical intervention within 3 months prior to study and/or a history of refractive surgery within 6 months prior to study. 5. have had any presence of active ocular infection (bacterial, viral, or fungal) or preauricular lymphadenopathy, or positive history of an ocular herpetic infection at their visits. 6. have had any uncontrolled systemic disease. 7. have had a history of status asthmaticus, a known history of persistent moderate or severe asthma, or a known history of moderate to severe allergic asthmatic reactions to study allergens. 8. have manifested signs or symptoms of clinically active allergic conjunctivitis (defined as the presence of any itching or >1 hyperemia in the conjunctival vessel bed) in either eye at the start visit. 9. be a female who was currently pregnant, nursing, or planning a pregnancy. 10. have used any of the disallowed medications (topical, topical ophthalmic, systemic and/or injectable) during the period indicated before and during the study period, including *aspirin, aspirin containing products *H1-antagonist antihistamines (including ocular) and all other anti-allergy therapies including prescription, over-the-counter, homeopathy agents *all other topical ophthalmic preparations (including tear substitutes) other than study drops *corticosteroids or mast cell stabilizers *depot corticosteroids

研究者

相似试验